Delivery Order SPE2DB22D2005-SPE2DB25FJJR7
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $5,241.50 and an ultimate completion date of May 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML medical products. The contract has a ceiling value of $12,115.98 and is a firm fixed-price delivery order, with an ultimate completion date of April 25, 2025. The contract is not set-aside and was awarded on April 24, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $4,457.82 contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a performance period ending on March 12, 2025. The contract is a Firm Fixed Price (FFP) arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product. The contract has a ceiling value of $7,010.65 and a performance period ending on April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,593.95 delivery order contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $4,080.10. The contract has an ultimate completion date of March 5, 2025 and is a firm fixed price contract. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This is a Delivery Order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML medical products. The award has a ceiling value of $5,738.22 and a period of performance through April 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $9,730.70 and a period of performance through February 20, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $3,506.69 and a performance period ending on March 24, 2025. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $6,081.82. The contract is a firm fixed-price delivery order and is not set-aside. The period of performance extends through May 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJJR7Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,212.74, is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML medical products. The contract has a period of performance through March 13, 2025 and utilizes a firm fixed price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.2k | 3/12/25 |